Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation
PLOS ONE · 2017
DOI: 10.1371/journal.pone.0175549 ↗Publications are organized using the same six research productions shown on the Research page. Some papers appear in more than one production when they directly connect multiple themes.
← Return to ResearchPublications examining reactive oxygen species, redox-sensitive immune signaling, inflammatory activation, and redox-based strategies in type 1 diabetes.
PLOS ONE · 2017
DOI: 10.1371/journal.pone.0175549 ↗Antioxidants & Redox Signaling · 2018
DOI: 10.1089/ars.2017.7357 ↗The Journal of Immunology · 2007
DOI: 10.4049/jimmunol.178.2.908 ↗Diabetes · 2002
DOI: 10.2337/diabetes.51.2.347 ↗Publications defining the metabolic requirements of autoreactive T cells and exploring immunometabolism as a therapeutic vulnerability in autoimmunity.
Frontiers in Immunology · 2021
DOI: 10.3389/fimmu.2021.669456 ↗PLOS ONE · 2017
DOI: 10.1371/journal.pone.0175549 ↗Immunometabolism · 2020
DOI: 10.20900/immunometab20200010 ↗Publications connecting endoplasmic reticulum stress, autophagy, inflammatory stress, neo-epitope formation, and increased beta cell immune visibility.
Frontiers in Immunology · 2025
DOI: 10.3389/fimmu.2025.1504583 ↗Frontiers in Endocrinology · 2021
DOI: 10.3389/fendo.2020.624590 ↗Frontiers in Endocrinology · 2017
DOI: 10.3389/fendo.2017.00262 ↗Frontiers in Cell and Developmental Biology · 2015
DOI: 10.3389/fcell.2015.00067 ↗Publications focused on detecting immune activation and disease-relevant biology before or during early stages of type 1 diabetes progression.
bioRxiv · 2026
DOI: 10.64898/2026.02.10.705171 ↗Publications using antigen-specific T cell systems to dissect activation, tolerance, diabetogenic function, and autoimmune progression.
bioRxiv · 2026
DOI: 10.64898/2026.02.10.705171 ↗The Journal of Immunology · 2007
DOI: 10.4049/jimmunol.178.2.908 ↗Methods in Molecular Medicine · 2004
DOI: 10.1385/1-59259-805-6:213 ↗Diabetes · 2002
DOI: 10.2337/diabetes.51.2.347 ↗Publications testing interventions, human islet biology, adoptive-transfer models, transplantation, and other systems that bridge mechanism with translational application.
Frontiers in Immunology · 2021
DOI: 10.3389/fimmu.2021.669456 ↗Diabetes · 2010
DOI: 10.2337/db09-0588 ↗Diabetes · 2004
DOI: 10.2337/diabetes.53.10.2559 ↗Diabetes · 2002
DOI: 10.2337/diabetes.51.8.2561 ↗Frontiers in Immunology · 2025
DOI: 10.3389/fimmu.2025.1504583 ↗